This report offers companies, investors, policymakers, and stakeholders crucial insight into the Philippines; one of the most promising pharmaceutical markets in the Asia-Pacific region with a population of over 100 million, an annual GDP growth rate of around 6.5%, and a…
With economic prosperity, political stability and significant growth prospects, Canada has much to admire. However, Canadians still lack universal drug coverage and Canadian health innovation has lagged behind that of the world leaders in this area. This report…
This report offers companies, investors, policymakers, and stakeholders crucial insight into the rich ecosystem of pharmaceuticals, biotech, and healthcare companies on Taiwan, based on in-depth interviews conducted with leaders and pioneers across the value chain, from…
Meanwhile the country’s newly appointed minister of health has been audacious in radically reshuffling the rules of the game to place public healthcare provision “firmly on a pathway to sustainability.” “A corner has been turned and we are well on the way to…
With steady GDP growth, political stability and the best healthcare system in Latin America, Colombia’s life sciences industry has all the ingredients for success laid out before it. Indeed, with the domestic pharmaceutical market set to grow at a rate of around 7.3…
This report offers companies, investors, policymakers, and stakeholders crucial insight into Ireland; a nation that stands poised to cement its position as a premier pharmaceuticals power, not just within Europe, but globally. In addition to its blossoming R&D…
With an admirable legacy of excellence behind it, Austria’s healthcare and life science industry is poised to take the next step and help make the country a genuine hub for both its region and for Europe. Vienna is already fast establishing itself as Central…